242 related articles for article (PubMed ID: 29673416)
1. Identification and Characterization of Asulam Impurities in Self Made Bulk Batch Synthesis and Quantification by RP-HPLC Method.
Mahaboob Basha D; Venkata Reddy G; Gopi Krishna Y; Kumara Swamy BE; Vijay R
J AOAC Int; 2018 Sep; 101(5):1448-1460. PubMed ID: 29673416
[TBL] [Abstract][Full Text] [Related]
2. Separation and estimation of process-related impurities of gefitinib by reverse-phase high-performance liquid chromatography.
Chandrashekara KA; Udupi A; Reddy CG
J Chromatogr Sci; 2014 Sep; 52(8):799-805. PubMed ID: 23897663
[TBL] [Abstract][Full Text] [Related]
3. Quantification of potential impurities by a stability indicating UV-HPLC method in niacinamide active pharmaceutical ingredient.
Thomas S; Bharti A; Tharpa K; Agarwal A
J Pharm Biomed Anal; 2012 Feb; 60():86-90. PubMed ID: 22115882
[TBL] [Abstract][Full Text] [Related]
4. Quantification and structural elucidation of potential impurities in agomelatine active pharmaceutical ingredient.
Liu Y; Chen L; Ji Y
J Pharm Biomed Anal; 2013; 81-82():193-201. PubMed ID: 23666256
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a reversed-phase liquid chromatographic method for analysis of demeclocycline and related impurities.
Kahsay G; Maxa J; Van Schepdael A; Hoogmartens J; Adams E
J Sep Sci; 2012 Jun; 35(10-11):1310-8. PubMed ID: 22733511
[TBL] [Abstract][Full Text] [Related]
6. High-performance liquid chromatographic determination of pantoprazole and its main impurities in pharmaceuticals.
Letica J; Marković S; Zirojević J; Nikolić K; Agbaba D
J AOAC Int; 2010; 93(4):1121-8. PubMed ID: 20922942
[TBL] [Abstract][Full Text] [Related]
7. A high pH based reversed-phase high performance liquid chromatographic method for the analysis of aminoglycoside plazomicin and its impurities.
Tan L; Wlasichuk KB; Schmidt DE; Campbell RL; Hirtzer P; Cheng L; Karr DE
J Pharm Biomed Anal; 2012 Jul; 66():75-84. PubMed ID: 22459505
[TBL] [Abstract][Full Text] [Related]
8. Assay of afoxolaner and determination of its related substances in commercial bulk batches of afoxolaner by reversed-phase HPLC method based on a short octadecyl column.
Padivitage N; Adhikari S; Rustum AM
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Nov; 1184():122984. PubMed ID: 34644667
[TBL] [Abstract][Full Text] [Related]
9. Development and Validation of a RP-HPLC Method for Determination of Related Substances and Degradants in Entacapone.
Purnachand D; Veerareddy A; Ramadevi B; Kameswarrao ChV; Madhusudhanreddy B
J Chromatogr Sci; 2016 Sep; 54(8):1310-23. PubMed ID: 27165569
[TBL] [Abstract][Full Text] [Related]
10. A Validated RP-HPLC Method for the Analysis of 1-Fluoronaphthalene and Its Process-Related Impurities.
Karagiannidou EG; Bekiari ET; Vastardi EI
J Chromatogr Sci; 2015 Sep; 53(8):1296-302. PubMed ID: 25713107
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous determination of piracetam and its four impurities by RP-HPLC with UV detection.
Arayne MS; Sultana N; Siddiqui FA; Mirza AZ; Qureshi F; Zuberi MH
J Chromatogr Sci; 2010 Aug; 48(7):589-94. PubMed ID: 20819285
[TBL] [Abstract][Full Text] [Related]
12. Stability-indicating RP-HPLC method development and validation for determination of nine impurities in apixaban tablet dosage forms. Robustness study by quality by design approach.
Subramanian VB; Katari NK; Dongala T; Jonnalagadda SB
Biomed Chromatogr; 2020 Jan; 34(1):e4719. PubMed ID: 31634417
[TBL] [Abstract][Full Text] [Related]
13. Development of a simple and stability-indicating RP-HPLC method for determining olanzapine and related impurities generated in the preparative process.
Cui D; Li Y; Lian M; Yang F; Meng Q
Analyst; 2011 Aug; 136(15):3149-56. PubMed ID: 21695344
[TBL] [Abstract][Full Text] [Related]
14. Stability Indicating RP-HPLC Method for Estimation of Potential Impurities in Ledipasvir and Characterization of a New Degradation Impurity.
Siva Kumar R; Sravan Kumar KV; Kondareddy L; Yogeshwara KR; Manish G; Jeenet J; Nitesh K
J Chromatogr Sci; 2018 May; 56(5):383-395. PubMed ID: 29474520
[TBL] [Abstract][Full Text] [Related]
15. Structural elucidation of potential impurities in Azilsartan bulk drug by HPLC.
Zhou W; Zhou Y; Sun L; Zou Q; Wei P; Ouyang P
J AOAC Int; 2014; 97(6):1552-62. PubMed ID: 25632433
[TBL] [Abstract][Full Text] [Related]
16. A stability indicating simultaneous dual wavelength UV-HPLC method for the determination of potential impurities in fampridine active pharmaceutical ingredient.
Thomas S; Shandilya S; Bharti A; Agarwal A
J Pharm Biomed Anal; 2012 Jan; 58():136-40. PubMed ID: 22000073
[TBL] [Abstract][Full Text] [Related]
17. A novel and rapid validated stability-indicating UPLC method of related substances for dorzolamide hydrochloride and timolol maleate in ophthalmic dosage form.
Sharma N; Rao SS; Reddy AM
J Chromatogr Sci; 2012 Oct; 50(9):745-55. PubMed ID: 22562819
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a stability-indicating RP-HPLC method for the simultaneous estimation of process related impurities and degradation products of rasagiline mesylate in pharmaceutical formulation.
Reddy PS; Sudhakar Babu K; Kumar N
J Chromatogr Sci; 2013 Mar; 51(3):242-9. PubMed ID: 22988002
[TBL] [Abstract][Full Text] [Related]
19. Reversed-phase liquid chromatography with electrospray mass detection and 1H and 13C NMR characterization of new process-related impurities, including forced degradants of efavirenz: related substances correlated to the synthetic pathway.
Gadapayale K; Kakde R; Sarma VU
J Sep Sci; 2015 Jan; 38(2):218-30. PubMed ID: 25385054
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a reversed phase liquid chromatographic method for analysis of oxytetracycline and related impurities.
Kahsay G; Shraim F; Villatte P; Rotger J; Cassus-Coussère C; Van Schepdael A; Hoogmartens J; Adams E
J Pharm Biomed Anal; 2013 Mar; 75():199-206. PubMed ID: 23277151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
